120 related articles for article (PubMed ID: 7355390)
1. Pathological fibrinolysis secondary to pseudoaneurysms.
Babu SC; Bole P; Sharma P; Purdy R; Clauss RH
Surgery; 1980 Feb; 87(2):202-4. PubMed ID: 7355390
[TBL] [Abstract][Full Text] [Related]
2. Use of TPA-induced clot lysis time (TCLOT) to diagnose abnormal clot structure and fibrinolysis in a patient with spontaneous bleeding into his leg.
Carr ME; Carr SL; McCardell KA
Angiology; 1996 Oct; 47(10):941-9. PubMed ID: 8873579
[TBL] [Abstract][Full Text] [Related]
3. Intrapulmonary clotting and fibrinolysis during abdominal aortic aneurysm surgery.
McLoughlin GA; Grindlinger GA; Manny J; Valeri CR; Lipinski B; Mannick JA; Hechtman HB
Ann Surg; 1979 Nov; 190(5):623-30. PubMed ID: 507973
[TBL] [Abstract][Full Text] [Related]
4. Consumption coagulopathy associated with arterial aneurysms.
Satiani B; Savrin R; Evans WE
J Cardiovasc Surg (Torino); 1979; 20(3):273-8. PubMed ID: 447764
[TBL] [Abstract][Full Text] [Related]
5. Coagulation in aortofemoral bifurcation bypass grafting.
von Sommoggy S; Fraunhofer S; Wahba A; Blümel G; Maurer PC
Eur J Vasc Surg; 1991 Jun; 5(3):247-53. PubMed ID: 1864390
[TBL] [Abstract][Full Text] [Related]
6. Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis.
Gould TJ; Vu TT; Stafford AR; Dwivedi DJ; Kim PY; Fox-Robichaud AE; Weitz JI; Liaw PC
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2544-53. PubMed ID: 26494232
[TBL] [Abstract][Full Text] [Related]
7. Coagulation and fibrinolysis system in aortic surgery under deep hypothermic circulatory arrest with aprotinin: the importance of adequate heparinization.
Okita Y; Takamoto S; Ando M; Morota T; Yamaki F; Matsukawa R; Kawashima Y
Circulation; 1997 Nov; 96(9 Suppl):II-376-81. PubMed ID: 9386127
[TBL] [Abstract][Full Text] [Related]
8. Changes in the coagulation of blood during resection of the abdominal aorta.
Mashiah A; Thomson JM; Poller L; Charlesworth D
Surg Gynecol Obstet; 1979 Aug; 149(2):214-6. PubMed ID: 462354
[TBL] [Abstract][Full Text] [Related]
9. Concepts of clot lysis.
Francis CW; Marder VJ
Annu Rev Med; 1986; 37():187-204. PubMed ID: 2939790
[TBL] [Abstract][Full Text] [Related]
10. Inherited fibrinolytic disorder due to an enhanced plasminogen activator level.
Aznar J; Estellés A; Vila V; Regañón E; España F; Villa P
Thromb Haemost; 1984 Oct; 52(2):196-200. PubMed ID: 6543037
[TBL] [Abstract][Full Text] [Related]
11. Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation.
Kang Y; Lewis JH; Navalgund A; Russell MW; Bontempo FA; Niren LS; Starzl TE
Anesthesiology; 1987 Jun; 66(6):766-73. PubMed ID: 3296855
[TBL] [Abstract][Full Text] [Related]
12. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.
Konieczynska M; Fil K; Bazanek M; Undas A
Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139
[TBL] [Abstract][Full Text] [Related]
13. Is use of aprotinin safe with deep hypothermic circulatory arrest in aortic surgery? Investigations on blood coagulation.
Okita Y; Takamoto S; Ando M; Morota T; Yamaki F; Kawashima Y
Circulation; 1996 Nov; 94(9 Suppl):II177-81. PubMed ID: 8901742
[TBL] [Abstract][Full Text] [Related]
14. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
von dem Borne PA; Cox LM; Bouma BN
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
[TBL] [Abstract][Full Text] [Related]
15. Increased plasma clot permeability and susceptibility to lysis are associated with heavy menstrual bleeding of unknown cause: a case-control study.
Szczepaniak P; Zabczyk M; Undas A
PLoS One; 2015; 10(4):e0125069. PubMed ID: 25909989
[TBL] [Abstract][Full Text] [Related]
16. Haemostasis in oral surgery--the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system.
Sindet-Pedersen S
Dan Med Bull; 1991 Dec; 38(6):427-43. PubMed ID: 1802633
[TBL] [Abstract][Full Text] [Related]
17. Unfavorably altered fibrin clot properties in patients with active rheumatoid arthritis.
Kwasny-Krochin B; Gluszko P; Undas A
Thromb Res; 2010 Jul; 126(1):e11-6. PubMed ID: 20471669
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of in situ fibrin degradation in pathologic thrombi.
Francis CW; Markham RE; Marder VJ
Blood; 1984 May; 63(5):1216-24. PubMed ID: 6231967
[TBL] [Abstract][Full Text] [Related]
19. Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations.
Petăjă J; Peltola K; Sairanen H; Leijala M; Kekomäki R; Vahtera E; Siimes MA
J Thorac Cardiovasc Surg; 1996 Sep; 112(3):665-71. PubMed ID: 8800154
[TBL] [Abstract][Full Text] [Related]
20. In vitro fibrin clot formation and fibrinolysis using heterozygous plasma fibrinogen from gammaAsn319, Asp320 deletion dysfibrinogen, Otsu I.
Terasawa F; Kani S; Hongo M; Okumura N
Thromb Res; 2006; 118(5):651-61. PubMed ID: 16412498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
